Articles Tagged With:
- 
          Intrauterine Hemorrhage-Control Devices for Postpartum Hemorrhage This multicenter, prospective, observational study comparing intrauterine balloon tamponade vs. vacuum-induced devices for postpartum hemorrhage demonstrated no difference in blood loss after device placement (median quantitative blood loss, 194 mL balloon vs. 240 mL vacuum; P = 0.40), need for blood transfusion (59.7% balloon vs. 50.0% vacuum; P = 0.08), need for more than three units of packed red blood cells (27.0% balloon vs. 24.9% vacuum; P = 0.53), or device failure (7.7% balloon vs. 8.5% vacuum; P = 0.70). 
- 
          Maternal Deaths, Illness Rise in Some States as Policy Changes Affect Reproductive Care Access New research shows that more pregnancy-capable people in the United States could have difficulty accessing contraceptives. Also, maternal deaths and morbidity are rising and could continue to rise because of additional policy changes. 
- 
          OB/GYNs Can Help Patients Struggling with Mental Health Issues Related to Dobbs OB/GYNs and reproductive healthcare providers can help young women cope with mental stress by providing support. 
- 
          Research Shows Providers Experiencing Distress Post-Dobbs Decision Researchers conducted in-depth interviews with clinicians — both in states with abortion bans and those without bans — about how changes in pregnancy care because of the Dobbs decision affected them. 
- 
          Potential Contraceptives, New Copper IUD May Offer More Non-Hormonal Options Some scientists have focused on finding a nonhormonal-based contraception option that would be effective and acceptable to people who want to stay away from hormones and their side effects. 
- 
          Relias Media is Now Clinician.com: What You Need to Know As of June 25, Relias Media is officially rebranding as Clinician.com. This change marks an exciting new chapter in how we serve healthcare professionals — but rest assured, everything you rely on today will remain the same. 
- 
          STEMI Watch 2025 Is Here! Written with Mission: Lifeline® hospitals in mind, STEMI Watch 2025: Clinical Excellence in Prevention, Management, and Intervention provides physicians and staff with a concise and practical update on ST-segment elevation myocardial infarction (STEMI). In the ninth edition of this series, you'll gain valuable STEMI CME/CE while reviewing clinically relevant recommendations to improve consistency of cardiac care for patients. 
- 
          Pediatric Tachycardia? The electrocardiogram in the figure is from a previously healthy 15-year-old boy who reports palpitations and dizziness over the past two weeks. How would you interpret this tachycardia? 
- 
          Avutometinib Capsules and Defactinib Tablets (Avmapki Fakzynja CO-PACK) The U.S. Food and Drug Administration has granted accelerated approval for a combination of two kinase inhibitors, avutometinib and defactinib, for the treatment of KRAS-mutated recurrent low-grade serous ovarian cancer who have received prior systemic therapy, including a platinum-based regimen. 
- 
          Why Does Colonization Become Active C. difficile? These authors performed a nested case-control study to identify risk factors for the progression from Clostridioides difficile colonization to active infection in hospitalized persons. 
